Stellantis Stock Climbs on Goldman Sachs Coverage Initiation
Shares of Stellantis (NYSE:STLA) experienced a 6.93% increase on November 23, 2025, as Goldman Sachs initiated coverage of the automaker with a Neutral rating. The stock price was listed at $9.87 following the initiation.
The company is concurrently engaged in a potential liability-restructuring deal with its Italian steel-component supplier, CLN-Coils Lamiere Nastri. This strategic move is aimed at stabilizing its supply chain. The proposed plan could involve asset sales, allowing banks to recover approximately half of their original exposure.
To reinforce its supply chain, Stellantis has agreed to pay more on its Italian supply contracts than previously negotiated. CLN is a long-standing partner that supplies crucial components such as wheels and metal sheets from its location near Fiat's historic Turin hub.
On the market, Stellantis stock saw a price change of $0.64, with trading for the day occurring between $9.59 and $9.96. The stock's 52-week high is $14.28 and the low is $8.39. The company's market capitalization stands at approximately $28.51 billion, with a trading volume of 20.04 million shares.
Stellantis N.V. (STLA) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.